Stock Analiz

Rani Therapeutics Holdings, Inc. (RANI) stock forecast and price target

Price $0.53 · data as of November 13, 2026

12-month price target

Average target$7.20
Upside / downside+1268.0%
Analysts5
ConsensusStrong buy
Low $5.00Average $7.20High $11.00

Gold marker: average target · white marker: today’s price ($0.53)

Analyst ratings

Strong buy 1Buy 4Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.17+62.8%$6M
Next fiscal year
ends December 31, 2027
$-0.19−13.4%$6M
Next quarter
ends December 31, 2026
$-0.04+38.1%$1M
Quarter after
ends December 31, 2026
$-0.05+28.6%$850000

Consensus of the analysts covering Rani Therapeutics, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Frequently asked questions

What is the Rani Therapeutics stock price target?

The average 12-month target from 5 analysts is $7.20, 1268.0% above the current price of $0.53 Targets range from $5.00 to $11.00.

Is Rani Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 4 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Rani Therapeutics expected to earn?

Analysts expect EPS of $-0.17 for the fiscal year ending December 31, 2026 and $-0.19 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.